Alphatec Spine, Inc.
9
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
44.4%
4 terminated/withdrawn out of 9 trials
20.0%
-66.5% vs industry average
0%
0 trials in Phase 3/4
200%
2 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Bone Mineral Density Precision Study
Role: lead
Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA
Role: lead
Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure
Role: lead
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
Role: lead
OsseoFix™ Spinal Fracture Reduction System in Treating Spinal Compression Fracture
Role: lead
PureGen: Radiographic Analysis of Fusion for ACDF
Role: lead
OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate
Role: lead
Gait and Balance in Thoracolumbar Spinal Deformity
Role: collaborator
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Role: lead
All 9 trials loaded